![John C. King](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John C. King
Corporate Officer/Principal presso VOR BIOPHARMA INC.
Provenienza dei contatti di primo grado di John C. King
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 114 | |
Subsidiary | Pharmaceuticals: Major | 18 | |
Public Company | Biotechnology | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John C. King tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer General Counsel | |
BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Investor Relations Contact Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Oldtech, Inc.
![]() Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Human Resources Officer Sales & Marketing | |
Novartis International AG
![]() Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ACCELERON PHARMA INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
BAXALTA INC | Biotechnology | Director/Board Member Human Resources Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | General Counsel Public Communications Contact Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Graduate Degree Masters Business Admin General Counsel | |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Public Communications Contact | |
CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
CRISPR THERAPEUTICS AG | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
Synlogic Operating Co., Inc.
![]() Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member Human Resources Officer General Counsel | |
NEON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Gemini Therapeutics Sub, Inc.
![]() Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
Cerevance, Inc.
![]() Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Operating Officer Director/Board Member Director of Finance/CFO | |
ALLOVIR, INC. | Biotechnology | President Chairman Director/Board Member | |
501 ACQU | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AKOUOS | Biotechnology | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 41 |
Svizzera | 4 |
Regno Unito | 3 |
Canada | 3 |
Belgio | 2 |
Settori
Health Technology | 40 |
Consumer Services | 6 |
Finance | 3 |
Health Services | 3 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 545 |
Corporate Officer/Principal | 267 |
Independent Dir/Board Member | 213 |
Chairman | 86 |
Undergraduate Degree | 83 |
Contatti più connessi
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
Stephen P. Squinto | 40 |
Joshua Resnick | 36 |
Ann Margaret Veneman | 34 |
Kush Parmar | 32 |
Felix Baker | 28 |
Rockford Norby | 28 |
Max E. Link | 28 |
Peter Bisgaard | 28 |
Francois Nader | 28 |
William Keller | 26 |
M. Burns | 23 |
Christopher Coughlin | 23 |
Abbie Celniker | 23 |
Jason Lettmann | 21 |
- Borsa valori
- Insiders
- John C. King
- Connessioni Società